GI Cancer

Failed bowel cancer trial finds silver lining

A trial exploring the use of a cancer stem cell inhibitor in advanced bowel cancer that terminated early due to futility may have uncovered a potential new treatment target. The double blind randomised phase 3 trial involved 282 patients with advanced bowel cancer recruited from 68 global cancer centres, including Australia. Patients were required to ...

Already a member?

Login to keep reading.

© 2022 the limbic